CEACAM5 and neoplasm: To better assess the application of exosomal Cripto-1 as a potential diagnosis marker, the study compared its ability to detect PHCCA with current diagnostic tools CA19-9 and CEA, the traditional serum tumor markers routinely used in clinic.